±Þ¼º ÀÓ±Õ¼º ¿äµµ¿°¿¡ ´ëÇÑ RosoxacinÀÇ ÀÓ»óÀû È¿°ú
Clinical Effect of Rosoxacin on Acute Gonococcal Urethritis
¼Ò¼Ó »ó¼¼Á¤º¸
¹æ°üÇö/Bang KH
ÇÑ¿µÅÃ/Han YT
KMID : 0358319830240040603
Abstract
Fourty gonococcal urethritis patients were treated with Rosoxacin at the Department of Urology, National Police Hospital from December, 1982 to April, 1983.
All patients were male and confirmed as acute gonococcal urethritis by Gram stain and culture.
A new bactericidal agent, Rosoxacin, was administered orally in a single dose of 300mg in 40 cases of acute gonococcal urethritis and following results were obtained.
1. Gram negative intracellular diplococci were controlled in 30 patients (100%) among 30 patients with pure gonococcal infection with a single oral dose of Rosoxacin.
2. 7 patients (23.3%) of 30 patients with pure gonococcal infection were revealed to nonspecific urethritis, and they were treated with other antibiotics.
3. Gram negative intracellular diplococci were controlled in 10 patients (100%) among 10 mixed infected patients with a single dose of Rosoxacin.
4. 8 patients (80%) of 10 patients with mixed infection were revealed to nonspecific urethritis, and they were treated with other antibiotics.
5. There was no side effect of Rosoxacin in all patients.
Å°¿öµå
ÀÓÁú; Ç×±ÕÁ¦; rosoxacin; acute gonococcal urethritis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸